Stephen C. Yabut

520 total citations
14 papers, 417 citations indexed

About

Stephen C. Yabut is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Stephen C. Yabut has authored 14 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Hematology. Recurrent topics in Stephen C. Yabut's work include Chemical Synthesis and Analysis (10 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Synthesis and Biological Evaluation (3 papers). Stephen C. Yabut is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Synthesis and Biological Evaluation (3 papers). Stephen C. Yabut collaborates with scholars based in United States and United Kingdom. Stephen C. Yabut's co-authors include Bruce E. Maryanoff, Michael J. Costanzo, Patricia Andrade‐Gordon, Jack A. Kauffman, Leonard R. Hecker, Lawrence de Garavilla, William J. Hoekstra, David F. McComsey, Harold R. Almond and Barbara J. Haertlein and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Stephen C. Yabut

14 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen C. Yabut United States 10 210 205 50 46 37 14 417
Edward C. Giardino United States 13 175 0.8× 174 0.8× 137 2.7× 53 1.2× 22 0.6× 20 507
Kokichi Suzuki Japan 10 144 0.7× 115 0.6× 71 1.4× 19 0.4× 86 2.3× 15 399
Jean Shearin United States 8 132 0.6× 139 0.7× 37 0.7× 10 0.2× 51 1.4× 8 427
Thomas H. Marsilje United States 14 247 1.2× 118 0.6× 53 1.1× 24 0.5× 64 1.7× 21 433
Gary A. Cain United States 11 261 1.2× 192 0.9× 30 0.6× 45 1.0× 50 1.4× 19 555
Craig I. Turner Australia 14 258 1.2× 285 1.4× 19 0.4× 37 0.8× 31 0.8× 18 599
Martina Fitzek United Kingdom 8 213 1.0× 91 0.4× 18 0.4× 38 0.8× 45 1.2× 21 369
Asaad Nematalla United States 7 269 1.3× 240 1.2× 39 0.8× 26 0.6× 123 3.3× 13 547
Yibin Zeng United States 15 208 1.0× 416 2.0× 44 0.9× 142 3.1× 111 3.0× 25 768
Carolyn A. Weigelt United States 14 255 1.2× 147 0.7× 20 0.4× 53 1.2× 169 4.6× 25 520

Countries citing papers authored by Stephen C. Yabut

Since Specialization
Citations

This map shows the geographic impact of Stephen C. Yabut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Yabut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Yabut more than expected).

Fields of papers citing papers by Stephen C. Yabut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Yabut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Yabut. The network helps show where Stephen C. Yabut may publish in the future.

Co-authorship network of co-authors of Stephen C. Yabut

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Yabut. A scholar is included among the top collaborators of Stephen C. Yabut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Yabut. Stephen C. Yabut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Maryanoff, Bruce E., John O’Neill, David F. McComsey, et al.. (2012). Pyrimidinopyrimidine inhibitors of ketohexokinase: Exploring the ring C2 group that interacts with Asp-27B in the ligand binding pocket. Bioorganic & Medicinal Chemistry Letters. 22(16). 5326–5329. 9 indexed citations
2.
Maryanoff, Bruce E., John O’Neill, David F. McComsey, et al.. (2011). Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. ACS Medicinal Chemistry Letters. 2(7). 538–543. 28 indexed citations
3.
Costanzo, Michael J., Stephen C. Yabut, Lawrence de Garavilla, et al.. (2008). Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives. Bioorganic & Medicinal Chemistry Letters. 18(6). 2114–2121. 43 indexed citations
4.
Costanzo, Michael J., Stephen C. Yabut, Han‐Cheng Zhang, et al.. (2008). Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase. 2. Investigation of the Carboxamide Portion of Spirocyclic Piperidine Amides. Letters in Drug Design & Discovery. 5(2). 116–121. 3 indexed citations
5.
Costanzo, Michael J., Harold R. Almond, Leonard R. Hecker, et al.. (2007). In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1‘ Subsite and Its Implications to Structure-Based Drug Design.. Journal of Medicinal Chemistry. 50(23). 5868–5868. 1 indexed citations
6.
Maryanoff, Bruce E., David F. McComsey, Michael J. Costanzo, et al.. (2006). Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa. Chemical Biology & Drug Design. 68(1). 29–36. 19 indexed citations
7.
Costanzo, Michael J., Harold R. Almond, Leonard R. Hecker, et al.. (2004). In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1‘ Subsite and Its Implications to Structure-Based Drug Design. Journal of Medicinal Chemistry. 48(6). 1984–2008. 54 indexed citations
8.
Lawson, Edward C., William A. Kinney, Michael J. Costanzo, et al.. (2004). Structure-Function Study of Quinazolinone-Based Vitronectin Receptor (αVβ3) Antagonists: Computer-Assisted Analysis of Ligand-Receptor Interactions. Letters in Drug Design & Discovery. 1(1). 14–18. 8 indexed citations
9.
Costanzo, Michael J., Stephen C. Yabut, Harold R. Almond, et al.. (2003). Potent, Small-Molecule Inhibitors of Human Mast Cell Tryptase. Antiasthmatic Action of a Dipeptide-Based Transition-State Analogue Containing a Benzothiazole Ketone. Journal of Medicinal Chemistry. 46(18). 3865–3876. 67 indexed citations
10.
Lawson, Edward C., William A. Kinney, Diane K. Luci, et al.. (2002). The Heck reaction with unprotected allylic amidines and guanidines. Tetrahedron Letters. 43(11). 1951–1953. 5 indexed citations
11.
Hoekstra, William J., Bruce E. Maryanoff, Bruce P. Damiano, et al.. (1999). Potent, Orally Active GPIIb/IIIa Antagonists Containing a Nipecotic Acid Subunit. Structure−Activity Studies Leading to the Discovery of RWJ-53308. Journal of Medicinal Chemistry. 42(25). 5254–5265. 60 indexed citations
12.
Hoekstra, William J., et al.. (1997). Solid-phase synthesis via N-terminal attachment to the 2-chlorotrityl resin. Tetrahedron Letters. 38(15). 2629–2632. 34 indexed citations
13.
Costanzo, Michael J., Bruce E. Maryanoff, Leonard R. Hecker, et al.. (1996). Potent Thrombin Inhibitors That Probe the S1‘ Subsite:  Tripeptide Transition State Analogues Based on a Heterocycle-Activated Carbonyl Group. Journal of Medicinal Chemistry. 39(16). 3039–3043. 61 indexed citations
14.
Hoekstra, William J., Bruce E. Maryanoff, Patricia Andrade‐Gordon, et al.. (1996). Solid-phase parallel synthesis applied to lead optimization: Discovery of potent analogues of the GPIIb/IIIa antagonist RWJ-50042. Bioorganic & Medicinal Chemistry Letters. 6(20). 2371–2376. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward C. Giardino Breakdown of academic impact, for papers by Kokichi Suzuki Breakdown of academic impact, for papers by Jean Shearin Breakdown of academic impact, for papers by Thomas H. Marsilje Breakdown of academic impact, for papers by Gary A. Cain Breakdown of academic impact, for papers by Craig I. Turner Breakdown of academic impact, for papers by Martina Fitzek Breakdown of academic impact, for papers by Asaad Nematalla Breakdown of academic impact, for papers by Yibin Zeng Breakdown of academic impact, for papers by Carolyn A. Weigelt
Rankless by CCL
2026